GlassScriptPhysician profile
Jonas P Berlin
NPI 1932545886
$964.41
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $840 · 2020: $91.77 · 2022: $14.00 · 2024: $19.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $246.90 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $177.19 | 2019 | |
| Abbvie INC. | $88.42 | 2019-2022 | |
| Novo Nordisk INC | $87.63 | 2019 | |
| Sanofi-Aventis U.S. LLC | $52.07 | 2019 | |
| Astellas Pharma US INC | $38.39 | 2019 | |
| Shire North American Group INC | $37.13 | 2019 | |
| Novartis Pharmaceuticals Corporation | $33.59 | 2019 | |
| Amgen INC. | $30.14 | 2019 | |
| Allergan, INC. | $29.88 | 2019-2020 | |
| Grifols USA, LLC | $22.97 | 2019 | |
| Pinnacle, INC | $19.13 | 2024 | |
| Neurocrine Biosciences, INC. | $14.11 | 2019 | |
| Sunovion Pharmaceuticals INC. | $13.79 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.01 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $12.74 | 2019 | |
| Merck Sharp & Dohme LLC | $12.57 | 2019 | |
| Horizon Therapeutics Plc | $12.55 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.23 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $10.97 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonas Berlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.